These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 14739095)

  • 41. Role of ammonia, inflammation, and cerebral oxygenation in brain dysfunction of acute-on-chronic liver failure patients.
    Sawhney R; Holland-Fischer P; Rosselli M; Mookerjee RP; Agarwal B; Jalan R
    Liver Transpl; 2016 Jun; 22(6):732-42. PubMed ID: 27028317
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mechanisms of cognitive alterations in hyperammonemia and hepatic encephalopathy: therapeutical implications.
    Monfort P; Cauli O; Montoliu C; Rodrigo R; Llansola M; Piedrafita B; El Mlili N; Boix J; Agustí A; Felipo V
    Neurochem Int; 2009; 55(1-3):106-12. PubMed ID: 19428813
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ammonia and the neutrophil in the pathogenesis of hepatic encephalopathy in cirrhosis.
    Shawcross DL; Shabbir SS; Taylor NJ; Hughes RD
    Hepatology; 2010 Mar; 51(3):1062-9. PubMed ID: 19890967
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nitric oxide, ammonia, and CRP levels in cirrhotic patients with hepatic encephalopathy: is there a connection?
    Papadopoulos N; Soultati A; Goritsas C; Lazaropoulou C; Achimastos A; Adamopoulos A; Dourakis SP
    J Clin Gastroenterol; 2010; 44(10):713-9. PubMed ID: 20495469
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy of rifaximin against covert hepatic encephalopathy and hyperammonemia in Japanese patients.
    Nakai M; Suda G; Ogawa K; Yoshida S; Hosoda S; Kubo A; Tokuchi Y; Kitagataya T; Yamada R; Shigesawa T; Ohara M; Sho T; Morikawa K; Sakamoto N
    PLoS One; 2022; 17(7):e0270786. PubMed ID: 35776720
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Helicobacter pylori, gastric juice, and arterial ammonia levels in patients with cirrhosis.
    Chakrabarti P; Zullo A; Hassan C; Pandit A; Chowdhury A; Santra A; Hazra B; Morini S; Roy T
    J Clin Gastroenterol; 2002; 34(5):578-81. PubMed ID: 11960074
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Systemic inflammation and ammonia in hepatic encephalopathy.
    Tranah TH; Vijay GK; Ryan JM; Shawcross DL
    Metab Brain Dis; 2013 Mar; 28(1):1-5. PubMed ID: 23224356
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neuropsychological and neurophysiological evaluation in cirrhotic patients with minimal hepatic encephalopathy undergoing liver transplantation.
    Senzolo M; Amodio P; D'Aloiso MC; Fagiuoli S; Del Piccolo F; Canova D; Masier A; Bassanello M; Zanus G; Burra P
    Transplant Proc; 2005 Mar; 37(2):1104-7. PubMed ID: 15848636
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hepatic encephalopathy is related to anemia and fat-free mass depletion in liver transplant candidates with cirrhosis.
    Kalaitzakis E; Josefsson A; Castedal M; Henfridsson P; Bengtsson M; Andersson B; Björnsson E
    Scand J Gastroenterol; 2013 May; 48(5):577-84. PubMed ID: 23452072
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Valproic acid-induced hyperammonemia and minimal hepatic encephalopathy prevalence among psychiatric inpatients.
    Thomas KL; La AQ; Punia S; Doroudgar S; Perry PJ
    Ann Clin Psychiatry; 2016 Feb; 28(1):37-42. PubMed ID: 26855984
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cognitive event-related potential in hepatic encephalopathy.
    Gallai V; Alberti A; Balò S; Mazzotta G; Clerici C; Gentili G; Firenze C; Morelli A
    Acta Neurol Scand; 1995 May; 91(5):358-61. PubMed ID: 7639065
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of zinc on liver cirrhosis with hyperammonemia: a preliminary randomized, placebo-controlled double-blind trial.
    Katayama K; Saito M; Kawaguchi T; Endo R; Sawara K; Nishiguchi S; Kato A; Kohgo H; Suzuki K; Sakaida I; Ueno Y; Habu D; Ito T; Moriwaki H; Suzuki K
    Nutrition; 2014; 30(11-12):1409-14. PubMed ID: 25280421
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Absence of neuropsychological impairment in hyperammonaemia in healthy young adults; possible synergism in development of hepatic encephalopathy (HE) symptoms?
    Wilkinson DJ; Smeeton NJ; Castle PC; Watt PW
    Metab Brain Dis; 2011 Sep; 26(3):203-12. PubMed ID: 21773808
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The diagnosis and prevalence of subclinical hepatic encephalopathy in apparently healthy, ambulant, non-shunted patients with cirrhosis.
    Gitlin N; Lewis DC; Hinkley L
    J Hepatol; 1986; 3(1):75-82. PubMed ID: 3745889
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ammonia-induced changes in pancreatic hormones and plasma amino acids in patients with liver cirrhosis.
    Marchesini G; Zoli M; Dondi C; Angiolini A; Melli A; Pisi E
    Dig Dis Sci; 1982 May; 27(5):406-12. PubMed ID: 7042253
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effect of induced hyperammonaemia on sleep and melanopsin-mediated pupillary light response in patients with liver cirrhosis: A single-blinded randomized crossover trial.
    Kann AE; Ba-Ali S; Seidelin JB; Larsen FS; Hamann S; Bjerring PN
    PLoS One; 2022; 17(9):e0275067. PubMed ID: 36170326
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inflammation: A novel target of current therapies for hepatic encephalopathy in liver cirrhosis.
    Luo M; Guo JY; Cao WK
    World J Gastroenterol; 2015 Nov; 21(41):11815-24. PubMed ID: 26557005
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development of a three-factor neuropsychological approach for detecting minimal hepatic encephalopathy.
    Stewart CA; Enders FT; Schneider N; Felmlee-Devine D; Kamath PS; Smith GE
    Liver Int; 2010 Jul; 30(6):841-9. PubMed ID: 20412441
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Persistent hyperammonemia is associated with complications and poor outcomes in patients with acute liver failure.
    Kumar R; Shalimar ; Sharma H; Prakash S; Panda SK; Khanal S; Acharya SK
    Clin Gastroenterol Hepatol; 2012 Aug; 10(8):925-31. PubMed ID: 22521861
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The usefulness of C-reactive protein and neutrophil-to-lymphocyte ratio for predicting the outcome in hospitalized patients with liver cirrhosis.
    Kwon JH; Jang JW; Kim YW; Lee SW; Nam SW; Jaegal D; Lee S; Bae SH
    BMC Gastroenterol; 2015 Oct; 15():146. PubMed ID: 26498833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.